Partner

Aude Ouensanga

Boston, USA

Aude advises start-ups and large global corporations in the U.S., EU, and Japan. Since joining Alira Health in 2012, Aude has managed over 100 corporate strategy, commercial due diligence, pre-commercial value assessments, and M&A projects in MedTech and Pharma. Previously, Aude was as an M&A analyst at BNP Paribas and a strategy analyst at Novartis Pharma. A registered U.S. investment banker with FINRA Series 79 and 63 certifications, Aude also manages Alira Health Ventures companies.

Highlights

Speaking engagements icon
20+
of speaking engagements/year
Years in industry icon
10+
of years in the industry
Projects completed
100+
of projects completed

Key areas of expertise

  • Drug Delivery Systems and Medical Contract Manufacturing
  • Infection Prevention
  • Wound Care
  • Digital Health
  • AI in Drug Discovery
  • Biopharmaceutical Assets and Pre-commercial Value Assessments

Languages spoken

United Kingdom flag icon English
French flag icon French
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.